In addition, Rho activator I calpeptin [24] also partially but significantly reversed the anti-migratory and anti-proliferative but not pro-apoptotic effects of ropivacaine (Fig. 4e to h), indicating that RhoA inhibition is involved in ropivacaine’s ability in inhibiting melanoma cell migration and growth but not survival. This evidence concerns the gene RHOA and melanoma.